Operating Income - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Operating Income Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Operating Income
-€29.7m
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Operating Income
-€136.2m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
Nanobiotix SA
PAR:NANO
Operating Income
-€26.8m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-13%
Innate Pharma SA
PAR:IPH
Operating Income
-€38.6m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
-15%
Genfit SA
NASDAQ:GNFT
Operating Income
-€26.7m
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
-10%
Eurobio Scientific SA
PAR:ALERS
Operating Income
€14.5m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Operating Income?
Operating Income
-29.7m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Operating Income amounts to -29.7m EUR.

What is Gensight Biologics SA's Operating Income growth rate?
Operating Income CAGR 5Y
2%

Over the last year, the Operating Income growth was -7%. The average annual Operating Income growth rates for Gensight Biologics SA have been -6% over the past three years , 2% over the past five years .

Back to Top